Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9600 | 1072 | 25.7 | 64% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2301 | 4109 | LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//APHERESIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LDL APHERESIS | Author keyword | 200 | 67% | 17% | 180 |
2 | LOW DENSITY LIPOPROTEIN APHERESIS | Author keyword | 98 | 79% | 6% | 62 |
3 | LIPOPROTEIN APHERESIS | Author keyword | 30 | 60% | 3% | 32 |
4 | LIPID APHERESIS | Author keyword | 22 | 62% | 2% | 23 |
5 | MEMBRANE DIFFERENTIAL FILTRATION | Author keyword | 21 | 90% | 1% | 9 |
6 | DIRECT ADSORPTION OF LIPOPROTEINS | Author keyword | 14 | 100% | 1% | 7 |
7 | LDL HEMOPERFUSION | Author keyword | 14 | 100% | 1% | 7 |
8 | FAMILIAL HYPERCHOLESTEROLEMIA | Author keyword | 12 | 11% | 10% | 107 |
9 | RHEOPHERESIS | Author keyword | 11 | 54% | 1% | 14 |
10 | HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | Author keyword | 10 | 39% | 2% | 21 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LDL APHERESIS | 159 | 58% | 17% | 183 |
2 | LIPID APHERESIS | 51 | 79% | 3% | 33 |
3 | ANGIOGRAPHICALLY ASSESSED TRIAL | 45 | 83% | 2% | 25 |
4 | DENSITY LIPOPROTEIN APHERESIS | 39 | 53% | 5% | 52 |
5 | DALI APHERESIS | 24 | 91% | 1% | 10 |
6 | PRECIPITATION HELP | 23 | 76% | 1% | 16 |
7 | LDL PRECIPITATION HELP | 21 | 90% | 1% | 9 |
8 | CELLULOSE ADSORPTION SYSTEM | 20 | 100% | 1% | 9 |
9 | AMPHIPHILIC ADSORBENT | 19 | 80% | 1% | 12 |
10 | DIRECT ADSORPTION | 16 | 58% | 2% | 18 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS SUPPLEMENTS | 7 | 15% | 4% | 41 |
2 | THERAPEUTIC APHERESIS | 6 | 18% | 3% | 28 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Recommendations for the use of LDL apheresis | 2008 | 122 | 46 | 89% |
LDL apheresis | 2003 | 99 | 84 | 82% |
A systematic review of LDL apheresis in the treatment of cardiovascular disease | 2006 | 37 | 41 | 78% |
Efficacy criteria and cholesterol targets for LDL apheresis | 2010 | 42 | 23 | 43% |
Current management of severe homozygous hypercholesterolaemias | 2004 | 52 | 79 | 52% |
Lipoprotein apheresis: an update | 2013 | 8 | 76 | 68% |
Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: Report of the first case and review of the literature | 2005 | 19 | 8 | 100% |
Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe | 2010 | 37 | 36 | 33% |
LDL apheresis: An effective and safe treatment for refractory hypercholesterolemia | 2002 | 13 | 18 | 94% |
LDL-Apheresis: Technical and Clinical Aspects | 2012 | 9 | 113 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLASM HE IS UNIT | 4 | 44% | 0.7% | 7 |
2 | EXTRACORPOREAL THER EUT TECH UNIT | 4 | 46% | 0.6% | 6 |
3 | AUTON NEUROENDOCRINOL | 2 | 36% | 0.5% | 5 |
4 | DOUBLE CHECK SWISS | 2 | 67% | 0.2% | 2 |
5 | MED METAB CARE GERONTOL 3 | 2 | 67% | 0.2% | 2 |
6 | NEUROL INTERNAL MED 3 | 2 | 50% | 0.3% | 3 |
7 | SOMAT | 2 | 33% | 0.4% | 4 |
8 | CLIN HEMOBIOTHER Y | 1 | 100% | 0.2% | 2 |
9 | EXTRACORPOREAL THER EUT TECH UNIT IMMUNOHEMATOL | 1 | 100% | 0.2% | 2 |
10 | LIPOPROT HE IS | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000154556 | BILIRUBIN REMOVAL//BILIRUBIN ADSORPTION//SPECIFIC SORBENTS |
2 | 0.0000142652 | FAMILIAL HYPERCHOLESTEROLEMIA//FAMILIAL HYPERCHOLESTEROLAEMIA//LDL RECEPTOR GENE |
3 | 0.0000118209 | PARTIAL ILEAL BYPASS//POSCH//ATHEROGENIC RATIO |
4 | 0.0000115840 | THERAPEUTIC APHERESIS//THERAPEUTIC PLASMA EXCHANGE//PLASMA EXCHANGE |
5 | 0.0000090009 | INTRAVENOUS INFUSION SETS//LIPOSORBER//ACHIRUS LINEATUS |
6 | 0.0000083003 | SEVERE HYPERTRIGLYCERIDEMIA//HYPERLIPIDEMIC PANCREATITIS//LIPEMIA RETINALIS |
7 | 0.0000080749 | ANIM PHYSIOL SECT//PROSORBA//PROTEIN A IMMOBILIZATION |
8 | 0.0000067023 | LIPOPROT UNIT//LIPOPROTEIN KINETICS//OURCE IL KINET ANAL |
9 | 0.0000060416 | LIPOPROTEINA//APOLIPOPROTEINA//LIPOPROTEIN A |
10 | 0.0000054593 | PCSK9//PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9//MIPOMERSEN |